Nifty
Sensex
:
:
17274.30
58065.47
386.95 (2.29%)
1276.66 (2.25%)

Pharmaceuticals & Drugs - Global

Rating :
57/99

BSE: 524742 | NSE: CAPLIPOINT

746.35
04-Oct-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 749.00
  • 759.40
  • 736.60
  • 746.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  36981
  •  278.01
  •  949.00
  •  626.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 5,650.93
  • 17.89
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 5,188.44
  • 0.54%
  • 3.78

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 68.88%
  • 1.99%
  • 20.77%
  • FII
  • DII
  • Others
  • 2.03%
  • 1.06%
  • 5.27%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 18.65
  • 13.72

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 15.10
  • 8.69

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 15.67
  • 11.73

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 21.84
  • 18.77
  • 18.01

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.84
  • 6.17
  • 3.86

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.77
  • 13.62
  • 11.51

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Net Sales
346.33
300.44
15.27%
339.24
278.71
21.72%
326.20
274.39
18.88%
303.53
268.12
13.21%
Expenses
244.15
207.83
17.48%
239.30
193.02
23.98%
225.24
190.46
18.26%
202.36
180.69
11.99%
EBITDA
102.18
92.61
10.33%
99.94
85.69
16.63%
100.96
83.93
20.29%
101.17
87.43
15.72%
EBIDTM
29.50%
30.82%
29.46%
30.75%
30.95%
30.59%
33.33%
32.61%
Other Income
13.94
9.21
51.36%
11.51
9.46
21.67%
9.54
5.82
63.92%
8.49
1.76
382.39%
Interest
0.06
0.27
-77.78%
0.08
0.32
-75.00%
0.14
0.28
-50.00%
0.21
0.48
-56.25%
Depreciation
10.97
12.03
-8.81%
11.45
9.86
16.13%
11.70
9.27
26.21%
11.72
8.88
31.98%
PBT
105.09
89.52
17.39%
99.92
84.97
17.59%
98.66
80.20
23.02%
97.73
79.83
22.42%
Tax
18.78
17.99
4.39%
19.09
17.05
11.96%
19.38
14.06
37.84%
20.91
17.00
23.00%
PAT
86.31
71.53
20.66%
80.83
67.92
19.01%
79.28
66.14
19.87%
76.82
62.83
22.27%
PATM
24.92%
23.81%
23.83%
24.37%
24.30%
24.10%
25.31%
23.43%
EPS
11.21
9.37
19.64%
10.43
8.77
18.93%
9.89
8.52
16.08%
9.91
7.52
31.78%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Net Sales
1,315.30
1,269.41
1,061.29
863.20
648.69
539.84
401.65
238.72
251.77
173.09
127.03
Net Sales Growth
17.26%
19.61%
22.95%
33.07%
20.16%
34.41%
68.25%
-5.18%
45.46%
36.26%
 
Cost Of Goods Sold
578.77
557.51
471.74
413.16
288.78
238.18
184.93
121.16
135.62
102.58
84.45
Gross Profit
736.53
711.90
589.55
450.04
359.91
301.66
216.72
117.56
116.15
70.50
42.58
GP Margin
56.00%
56.08%
55.55%
52.14%
55.48%
55.88%
53.96%
49.25%
46.13%
40.73%
33.52%
Total Expenditure
911.05
874.88
737.04
603.13
416.84
344.52
276.84
174.51
192.06
136.90
104.68
Power & Fuel Cost
-
21.40
16.36
14.81
13.76
10.98
9.91
7.56
8.61
3.07
1.12
% Of Sales
-
1.69%
1.54%
1.72%
2.12%
2.03%
2.47%
3.17%
3.42%
1.77%
0.88%
Employee Cost
-
114.74
101.97
67.15
45.58
37.61
29.71
17.92
18.24
12.63
7.69
% Of Sales
-
9.04%
9.61%
7.78%
7.03%
6.97%
7.40%
7.51%
7.24%
7.30%
6.05%
Manufacturing Exp.
-
82.01
69.85
68.23
43.49
37.11
28.56
14.33
16.04
7.42
3.07
% Of Sales
-
6.46%
6.58%
7.90%
6.70%
6.87%
7.11%
6.00%
6.37%
4.29%
2.42%
General & Admin Exp.
-
49.16
38.53
25.50
20.82
12.27
13.78
8.15
7.97
6.54
4.67
% Of Sales
-
3.87%
3.63%
2.95%
3.21%
2.27%
3.43%
3.41%
3.17%
3.78%
3.68%
Selling & Distn. Exp.
-
27.51
18.03
9.95
2.08
5.92
9.41
2.29
2.85
1.46
1.02
% Of Sales
-
2.17%
1.70%
1.15%
0.32%
1.10%
2.34%
0.96%
1.13%
0.84%
0.80%
Miscellaneous Exp.
-
22.55
20.56
4.33
2.33
2.45
0.55
3.10
2.72
3.19
1.02
% Of Sales
-
1.78%
1.94%
0.50%
0.36%
0.45%
0.14%
1.30%
1.08%
1.84%
2.09%
EBITDA
404.25
394.53
324.25
260.07
231.85
195.32
124.81
64.21
59.71
36.19
22.35
EBITDA Margin
30.73%
31.08%
30.55%
30.13%
35.74%
36.18%
31.07%
26.90%
23.72%
20.91%
17.59%
Other Income
43.48
38.89
27.93
41.33
19.03
12.67
9.96
3.66
3.03
3.72
2.10
Interest
0.49
0.70
1.59
0.32
0.58
0.61
0.52
0.34
0.97
0.68
0.77
Depreciation
45.84
46.90
36.97
31.62
23.43
19.00
13.30
7.48
8.38
3.54
1.54
PBT
401.40
385.82
313.62
269.46
226.88
188.38
120.95
60.05
53.39
35.69
22.14
Tax
78.16
77.37
62.19
54.38
50.32
43.74
25.44
14.28
12.26
9.76
8.12
Tax Rate
19.47%
20.05%
19.83%
20.18%
22.18%
23.22%
21.03%
23.78%
22.96%
27.35%
36.68%
PAT
323.24
299.84
242.27
215.00
176.56
144.78
95.61
45.77
41.04
25.85
13.98
PAT before Minority Interest
313.98
308.45
251.43
215.08
176.56
144.63
95.50
45.77
41.13
25.93
14.02
Minority Interest
-9.26
-8.61
-9.16
-0.08
0.00
0.15
0.11
0.00
-0.09
-0.08
-0.04
PAT Margin
24.58%
23.62%
22.83%
24.91%
27.22%
26.82%
23.80%
19.17%
16.30%
14.93%
11.01%
PAT Growth
20.42%
23.76%
12.68%
21.77%
21.95%
51.43%
108.89%
11.53%
58.76%
84.91%
 
EPS
42.64
39.56
31.96
28.36
23.29
19.10
12.61
6.04
5.41
3.41
1.84

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Shareholder's Funds
1,483.93
1,185.83
947.91
632.91
363.83
224.76
128.14
93.19
61.74
43.14
Share Capital
89.74
89.71
89.71
51.05
15.12
15.12
15.11
15.11
15.11
15.11
Total Reserves
1,385.24
1,081.33
848.76
575.01
345.42
209.56
111.40
78.08
46.63
28.03
Non-Current Liabilities
12.55
17.39
24.86
23.42
27.86
19.90
13.69
10.39
10.42
8.66
Secured Loans
0.00
0.00
0.02
0.29
0.32
0.48
0.73
0.88
2.07
3.48
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
8.48
5.69
5.23
0.13
0.00
0.40
1.63
0.82
0.81
0.38
Current Liabilities
207.68
142.85
144.32
86.11
108.67
113.36
125.04
124.97
107.58
83.01
Trade Payables
163.18
88.50
64.14
60.47
94.23
78.60
55.71
41.56
31.50
25.64
Other Current Liabilities
41.94
51.87
79.28
24.20
13.86
33.09
60.39
72.11
66.42
50.85
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.05
0.05
0.05
Short Term Provisions
2.56
2.48
0.91
1.44
0.58
1.67
8.94
11.25
9.60
6.47
Total Liabilities
1,730.11
1,363.61
1,125.75
742.52
500.45
358.38
267.14
228.82
179.92
134.90
Net Block
286.57
305.34
272.50
226.84
169.48
151.83
144.23
113.13
102.24
32.71
Gross Block
445.74
422.58
354.79
271.51
231.79
195.15
180.76
142.71
123.06
50.06
Accumulated Depreciation
159.17
117.24
82.29
44.67
62.31
43.31
36.53
29.58
20.82
17.36
Non Current Assets
432.29
349.04
303.23
248.83
196.34
179.16
148.61
146.95
131.30
96.21
Capital Work in Progress
17.73
13.88
20.12
9.70
15.29
3.42
0.23
30.63
24.54
48.98
Non Current Investment
37.01
0.66
0.56
0.33
0.33
13.24
0.44
0.45
0.44
1.19
Long Term Loans & Adv.
89.90
7.92
10.05
11.95
11.23
10.67
3.71
2.75
3.67
10.83
Other Non Current Assets
1.08
21.24
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
1,297.82
1,014.57
822.53
493.69
304.11
179.22
118.53
81.87
48.61
38.70
Current Investments
51.97
10.54
60.23
69.62
46.34
4.20
0.00
0.00
0.00
0.00
Inventories
227.31
179.01
238.23
37.45
28.46
22.29
18.81
13.66
9.79
10.42
Sundry Debtors
320.06
279.36
228.96
159.81
125.88
33.02
7.95
5.66
0.09
0.86
Cash & Bank
462.99
438.33
223.43
152.99
79.28
93.07
68.10
45.37
26.82
16.84
Other Current Assets
235.49
20.25
14.87
9.22
24.16
26.63
23.67
17.18
11.90
10.57
Short Term Loans & Adv.
221.88
87.08
56.81
64.61
17.28
19.31
12.58
11.08
8.16
5.61
Net Current Assets
1,090.14
871.72
678.21
407.58
195.44
65.86
-6.51
-43.10
-58.97
-44.31
Total Assets
1,730.11
1,363.61
1,125.76
742.52
500.45
358.38
267.14
228.82
179.91
134.91

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Cash From Operating Activity
336.75
268.61
44.68
83.42
66.49
67.61
42.40
49.88
59.83
31.95
PBT
385.82
313.62
269.46
226.88
188.38
120.95
60.05
53.39
35.69
22.14
Adjustment
30.44
23.09
7.09
19.12
14.84
8.61
3.87
6.21
2.14
-0.21
Changes in Working Capital
1.99
-1.96
-177.11
-120.06
-100.38
-38.39
-5.13
1.96
29.32
15.81
Cash after chg. in Working capital
418.25
334.75
99.44
125.94
102.84
91.16
58.78
61.56
67.15
37.75
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-81.50
-66.14
-54.76
-42.51
-36.35
-23.55
-16.38
-11.67
-7.32
-5.80
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-270.94
-29.44
-54.50
-100.46
-69.02
-36.11
-5.72
-22.66
-43.89
-45.44
Net Fixed Assets
-3.66
-35.46
-43.65
58.45
-48.43
-19.56
-7.66
-25.72
-48.50
-43.00
Net Investments
-115.52
46.59
-27.53
-120.03
-29.43
-17.35
0.01
-0.90
0.75
-0.05
Others
-151.76
-40.57
16.68
-38.88
8.84
0.80
1.93
3.96
3.86
-2.39
Cash from Financing Activity
-40.71
-23.98
79.77
89.79
-11.60
-6.74
-13.95
-8.67
-5.96
-1.48
Net Cash Inflow / Outflow
25.10
215.19
69.94
72.76
-14.13
24.76
22.73
18.55
9.99
-14.97
Opening Cash & Equivalents
435.72
220.77
150.65
77.17
91.31
66.55
45.37
26.82
16.84
31.80
Closing Cash & Equivalent
460.73
435.72
220.77
150.65
77.17
91.31
68.10
45.37
26.82
16.84

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Book Value (Rs.)
184.75
144.94
114.21
78.03
47.69
29.73
16.25
11.84
7.68
5.22
ROA
19.94%
20.20%
23.02%
28.41%
33.68%
30.54%
18.46%
20.12%
16.48%
11.59%
ROE
24.71%
25.65%
29.58%
37.14%
49.43%
54.97%
43.13%
55.78%
53.24%
40.49%
ROCE
28.77%
28.82%
33.35%
45.59%
64.08%
69.03%
55.41%
71.11%
68.99%
56.69%
Fixed Asset Turnover
2.92
2.73
2.76
2.58
2.53
2.14
1.48
1.89
2.00
2.73
Receivable days
86.18
87.41
82.19
80.37
53.72
18.62
10.40
4.17
1.00
11.66
Inventory Days
58.42
71.75
58.28
18.54
17.16
18.68
24.83
17.00
21.31
24.06
Payable days
82.39
59.05
28.33
65.76
89.68
88.17
103.48
69.75
79.69
85.60
Cash Conversion Cycle
62.21
100.11
112.15
33.15
-18.80
-50.88
-68.24
-48.58
-57.39
-49.89
Total Debt/Equity
0.00
0.01
0.04
0.00
0.00
0.00
0.02
0.02
0.06
0.12
Interest Cover
552.17
198.25
843.86
391.22
309.72
235.08
179.35
56.11
53.29
29.73

News Update:


  • Caplin Point selected under Forbes Asia’s ‘200 best under billion list’
    22nd Aug 2022, 16:24 PM

    Forbes Asia has selected 200 best performing companies, with revenues of less than a billion

    Read More
  • Caplin Point Lab - Quarterly Results
    5th Aug 2022, 13:06 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.